World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
94
Citations
65285
World Ranking
548
National Ranking
253

Medicine

D-Index
94
Citations
66400
World Ranking
10234
National Ranking
5262

Thomas F. Patterson publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Thomas F. Patterson sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 323 publications — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Thomas F. Patterson D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas F. Patterson sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 94 D-Index — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Thomas F. Patterson is affiliated with The University of Texas Health Science Center at San Antonio in the United States. Their body of work is primarily situated within the field of Medicine, with a significant focus on Infectious Diseases, Epidemiology, Neurology, Cell Biology, and Pharmacology.

Their research extensively covers several key topics including:

  • Antifungal resistance and susceptibility
  • Fungal infections and studies
  • COVID-19 clinical research studies
  • SARS-CoV-2 and COVID-19 research
  • Long-term effects of COVID-19
  • Plant pathogens and fungal diseases
  • Nail diseases and treatments

Patterson has published numerous papers with notable recent works such as:

  • Remdesivir for the Treatment of Covid-19 - Final Report, 2020, New England Journal of Medicine
  • Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19, 2020, New England Journal of Medicine
  • Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance, 2020, The Lancet Infectious Diseases
  • Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion, 2020, Intensive Care Medicine
  • Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology, 2021, The Lancet Infectious Diseases

Frequent co-authors collaborating with Patterson include:

  • Nathan P. Wiederhold
  • George R. Thompson
  • Luis Ostrosky-Zeichner
  • Oliver A. Cornely
  • Peter G. Pappas

Their research has been published frequently in the following venues:

  • Antimicrobial Agents and Chemotherapy
  • Open Forum Infectious Diseases
  • The Lancet Infectious Diseases
  • Clinical Infectious Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)

Best Publications

  • Remdesivir for the Treatment of Covid-19 - Final Report.

    John H. Beigel;Kay M. Tomashek;Lori E. Dodd;Aneesh K. Mehta

  • Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

    Ben De Pauw;Thomas J. Walsh;J. Peter Donnelly;David A. Stevens

  • Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis

    Raoul Herbrecht;David W. Denning;David W. Denning;Thomas F. Patterson;John E. Bennett

  • Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

    Thomas J. Walsh;Elias J. Anaissie;David W. Denning;Raoul Herbrecht

  • Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America

    Thomas F. Patterson;George Richard Thompson;David W. Denning;Jay A. Fishman

  • Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus

    S. Ascioglu;J. H. Rex;B. De Pauw;J. E. Bennett

  • Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

    J. Peter Donnelly;Sharon C. Chen;Carol A. Kauffman;William J. Steinbach

  • Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database

    Dimitrios P. Kontoyiennis;Kieren A. Marr;Benjamin J. Park;Barbara D. Alexander

  • Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.

    Andre C Kalil;Thomas F Patterson;Aneesh K Mehta;Kay M Tomashek

  • Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant‐Associated Infection Surveillance Network (TRANSNET)

    Peter G. Pappas;Barbara D. Alexander;David R. Andes;Susan Hadley

  • Practice Guidelines for Diseases Caused by Aspergillus

    David A. Stevens;David A. Stevens;David A. Stevens;Virginia L. Kan;Virginia L. Kan;Marc A. Judson;Marc A. Judson;Vicki A. Morrison

  • Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

    Johan A. Maertens;Issam I. Raad;Kieren A. Marr;Thomas F. Patterson

  • Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group.

    Thomas F. Patterson;William R. Kirkpatrick;Mary White;John W. Hiemenz

  • Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.

    Philipp Koehler;Matteo Bassetti;Arunaloke Chakrabarti;Sharon C.A. Chen;Sharon C.A. Chen

  • Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: An externally controlled trial

    Thomas J. Walsh;Issam Raad;Thomas F. Patterson;Pranatharthi Chandrasekar

  • Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal Therapy

    Johan Maertens;Issam Raad;George Petrikkos;Marc Boogaerts

  • Imaging findings in acute invasive pulmonary aspergillosis: Clinical significance of the halo sign

    Reginald E. Greene;Haran T. Schlamm;Jörg W. Oestmann;Paul Stark

  • Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment

    Maiken Cavling Arendrup;Thomas F Patterson

  • Prevalence of Molecular Mechanisms of Resistance to Azole Antifungal Agents in Candida albicans Strains Displaying High-Level Fluconazole Resistance Isolated from Human Immunodeficiency Virus-Infected Patients

    Sofia Perea;José L. López-Ribot;William R. Kirkpatrick;Robert K. McAtee

  • Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria

    Brahm H. Segal;Raoul Herbrecht;David A. Stevens;David A. Stevens;Luis Ostrosky-Zeichner

  • Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms

    Gordon Ramage;Stefano Bachmann;Thomas F. Patterson;Brian L. Wickes

Frequent Co-Authors

Nathan P. Wiederhold
Nathan P. Wiederhold The University of Texas Health Science Center at San Antonio
Michael G. Rinaldi
Michael G. Rinaldi The University of Texas Health Science Center at San Antonio
Annette W. Fothergill
Annette W. Fothergill The University of Texas Health Science Center at San Antonio
Laura K. Najvar
Laura K. Najvar The University of Texas Health Science Center at San Antonio
Jose L. Lopez-Ribot
Jose L. Lopez-Ribot The University of Texas at San Antonio
Kieren A. Marr
Kieren A. Marr Johns Hopkins University School of Medicine
David W. Denning
David W. Denning University of Manchester
John R. Graybill
John R. Graybill The University of Texas Health Science Center at San Antonio
John R. Wingard
John R. Wingard University of Florida
Thomas J. Walsh
Thomas J. Walsh Weill Cornell Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their knowledge beyond microbiology, various online degree programs offer practical pathways in healthcare and related fields. For example, students looking to enter the administrative side of healthcare can explore fast online medical billing and coding certification programs. These programs are designed to be completed quickly, preparing graduates for roles that support medical facilities with essential coding and billing tasks.

Those wanting to pursue broader healthcare roles may consider online healthcare degrees that pay well, offering a variety of options from nursing to health informatics. These degrees blend flexibility with strong career prospects, making them ideal for working professionals.

Public health is another complementary field, with many students enrolling in online public health masters programs easy to get into. These programs are accessible and provide essential training to address community health challenges, policy, and management.

Additionally, career paths focusing on child development and well-being, such as becoming a child life specialist, offer fulfilling work with competitive compensation. You can learn more about earning potential by reading about child specialist salary.

Best Scientists Citing Thomas F. Patterson

Trending Scientists

Recently Published Articles